Please provide your email address to receive an email when new articles are posted on . The use of extracorporeal membrane oxygenation support as a bridge to lung transplantation in children increased ...
The use of extracorporeal membrane oxygenation (ECMO) is continuing to grow, with 77,542 patients in North America receiving the form of life support in the past five years, according to the ...
To describe the use of double-lumen venovenous (VVDL) extracorporeal membrane oxygenation (ECMO) with cephalic draining cannula (VVDL+V) as a primary approach for all neonatal respiratory diagnoses ...
DALLAS, Nov. 6, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic ...
Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HONOLULU -- In ...
Natalya Manhertz, once a thriving teen athlete, defied death through ECMO support after a rare infection led to sepsis, ...
Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may be just as ...
In patients with rapidly deteriorating or severe cardiogenic shock, immediate use of extracorporeal membrane oxygenation (ECMO) does not improve outcomes over an initially conservative strategy with ...
Around 60% of patients with COVID-19 who receive extracorporeal membrane oxygenation (ECMO) support survive to 90 days, according to registry data from 213 hospitals in 36 countries. The analysis, ...
The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but ...